About the OSU College of Pharmacy: The College of Pharmacy prepares students of today to be the pharmacy practitioners and pharmaceutical sciences researchers of tomorrow by contributing to improved health, advancing patient care and the discovery and understanding of medicines.
PORTLAND, Ore. – Researchers at Oregon State University have developed a technique for simultaneously treating lung cancer and a serious muscle-wasting condition that often accompanies it.
The study, published in the Journal of Controlled Release, involves lipid nanoparticles delivering therapeutic genetic material to lung tumors.
PORTLAND, Ore. – Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells.
Findings of the study spearheaded by Oregon State University College of Pharmacy graduate student Antony Jozić were published today in Nature Biotechnology.
PORTLAND, Ore. – Researchers at Oregon State University have developed and tested in a mouse model a new type of nanoparticle that enables the removal of melanoma tumors with a low-power laser.
After the systemically administered nanoparticles accumulate in cancerous tissue, exposure to near-infrared light causes them to heat up and destroy the melanoma cells, leaving healthy tissue unharmed.
PORTLAND, Ore. – Scientists at Oregon State University have developed a new nanomaterial that triggers a pair of chemical reactions inside cancer cells, killing the cells via oxidative stress while leaving healthy tissues alone.
The study led by Oleh and Olena Taratula and Chao Wang of the OSU College of Pharmacy was published this week in Advanced Functional Materials.
CORVALLIS, Ore. – “Magic mushroom” edibles sold at smoke shops and convenience stores are likely to contain no psilocybin but instead a range of undisclosed active ingredients, a study led by an Oregon State University College of Pharmacy scientist shows.
The research collaboration, which included a state-certified testing laboratory and a scientific instrument manufacturer, published its findings today in JAMA Network Open, a journal of the American Medical Association.
PORTLAND, Ore. – Scientists have made a key breakthrough for treating respiratory diseases by developing a new drug delivery system that transports genetic therapies directly to the lungs, opening promising possibilities for patients with conditions like lung cancer and cystic fibrosis.
PORTLAND, Ore. – Oregon State University researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer’s disease, multiple sclerosis, Parkinson’s disease and cancer cachexia.
The delivery method involves specially engineered nanoparticles, tiny bits of matter no larger than 100 billionths of a meter.
CORVALLIS, Ore. – More than two-fifths of Oregon community pharmacies require a prescription to purchase syringes, even though they can be sold over the counter, creating an access barrier that could exacerbate the spread of bloodborne diseases like hepatitis C.
PORTLAND, Ore. – New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a breakthrough for treating ovarian tumors and possibly other types of cancer, according to the Oregon State University researchers who developed them.
The scientists say the study underscores the importance of shape in magnetic nanoparticle design and that the findings will potentially revolutionize treatments that use heat to damage or kill cancer cells.
PORTLAND, Ore. – A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.
Scientists led by Olena Taratula, a nanomedicine researcher at Oregon State University, have found a way to better ensure the drug used to combat the disease reaches tumor cells without damaging healthy tissue.
